[Superbugs Neisseria gonorrhoeae und Mycoplasma genitalium : Therapeutic challenges driven by antimicrobial resistance]. [PDF]
Kogler A, Chromy D, Sadoghi B.
europepmc +1 more source
Stepwise evolution and clonal enrichment of gepotidacin resistance in <i>Neisseria gonorrhoeae</i>. [PDF]
Yao L +12 more
europepmc +1 more source
Genetic background modulates zoliflodacin and gepotidacin cross-resistance and fitness in Neisseria gonorrhoeae. [PDF]
Mukherjee A +5 more
europepmc +1 more source
Point-of-care Tests for Chlamydia trachomatis and Neisseria gonorrhoeae: Review of the Literature. [PDF]
Manabe YC +4 more
europepmc +1 more source
First Study on Antimicrobial Susceptibility and Molecular Epidemiology of <i>Neisseria gonorrhoeae</i> Isolates from Infertile Women. [PDF]
Huang Y +7 more
europepmc +1 more source
Tetracycline Resistance Among Neisseria gonorrhoeae Isolates-United States, 1987-2022. [PDF]
Wondmeneh S +8 more
europepmc +1 more source
Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae. [PDF]
Allan-Blitz LT, Klausner JD.
europepmc +1 more source
Prevalence and epidemiological patterns of Neisseria gonorrhoeae infection in Canada, 1969-2025: a systematic review and meta-analysis. [PDF]
Harfouche M +5 more
europepmc +1 more source
Identification of the cannabinoid receptor 1 antagonist, ibipinabant, as a potent inhibitor of <i>Neisseria gonorrhoeae</i>. [PDF]
Dove AS +3 more
europepmc +1 more source

